Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18398808rdf:typepubmed:Citationlld:pubmed
pubmed-article:18398808lifeskim:mentionsumls-concept:C0086287lld:lifeskim
pubmed-article:18398808lifeskim:mentionsumls-concept:C0037315lld:lifeskim
pubmed-article:18398808lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:18398808lifeskim:mentionsumls-concept:C0004048lld:lifeskim
pubmed-article:18398808lifeskim:mentionsumls-concept:C0010362lld:lifeskim
pubmed-article:18398808lifeskim:mentionsumls-concept:C0754710lld:lifeskim
pubmed-article:18398808lifeskim:mentionsumls-concept:C0669479lld:lifeskim
pubmed-article:18398808pubmed:issue1lld:pubmed
pubmed-article:18398808pubmed:dateCreated2008-4-9lld:pubmed
pubmed-article:18398808pubmed:abstractTextSleep-disordered breathing (SDB) is often encountered in morbid obesity (MO) in conjunction with insulin resistance (IR). Aminoterminal pro-brain natriuretic peptide (NT-proBNP) is a promising marker for left ventricular dysfunction (LVD) in MO. We sought to explore the factors that may influence the relationships of SDB and IR with NT-proBNP in MO women. We performed a cross-sectional pilot study involving 110 asymptomatic MO (44.5+/-0.7 kg/m2) young women. SDB risk was assessed using a modified version of the Berlin Questionnaire (BQ). IR was assessed using the homeostasis model assessment (HOMA) index and adiponectin levels. LVD was assessed using NT-proBNP and echocardiograms. In this study, NT-proBNP levels and LVD increased significantly along the BQ strata. Multiple regression analysis identified BQ and log-transformed HOMA as the independent variables predicting as much as 48.0% of the variability of logNT-proBNP. In conclusion, NT-pro-BNP levels are independently predicted by SDB and IR in asymptomatic MO women. Larger prospective studies are warranted.lld:pubmed
pubmed-article:18398808pubmed:languageenglld:pubmed
pubmed-article:18398808pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18398808pubmed:citationSubsetIMlld:pubmed
pubmed-article:18398808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18398808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18398808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18398808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18398808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18398808pubmed:statusMEDLINElld:pubmed
pubmed-article:18398808pubmed:monthMarlld:pubmed
pubmed-article:18398808pubmed:issn1479-1641lld:pubmed
pubmed-article:18398808pubmed:authorpubmed-author:JosephP MPMlld:pubmed
pubmed-article:18398808pubmed:authorpubmed-author:PlanasFrances...lld:pubmed
pubmed-article:18398808pubmed:authorpubmed-author:YbarraJuanJlld:pubmed
pubmed-article:18398808pubmed:issnTypePrintlld:pubmed
pubmed-article:18398808pubmed:volume5lld:pubmed
pubmed-article:18398808pubmed:ownerNLMlld:pubmed
pubmed-article:18398808pubmed:authorsCompleteYlld:pubmed
pubmed-article:18398808pubmed:pagination19-24lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:meshHeadingpubmed-meshheading:18398808...lld:pubmed
pubmed-article:18398808pubmed:year2008lld:pubmed
pubmed-article:18398808pubmed:articleTitleAminoterminal pro-brain natriuretic peptide (NT-proBNP) and sleep-disordered breathing in morbidly obese females: a cross-sectional study.lld:pubmed
pubmed-article:18398808pubmed:affiliationInstituto de Cardiología y Medicina Avanzada , Centro Médico Teknon, C/ Vilana 12, 08021 Barcelona, Spain. juanybarra@hotmail.comlld:pubmed
pubmed-article:18398808pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18398808pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18398808lld:pubmed